Coherus Oncology, Inc. Business Combination, Contingent Consideration, Liability, Current
Coherus Oncology, Inc. (CHRS) had Business Combination, Contingent Consideration, Liability, Current of $3.30 million as of 2023-12-31, per its 8-K filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2025-11-13
- 2023-12-31: Business Combination, Contingent Consideration, Liability, Current $3.30M.
- 2023-09-30: Business Combination, Contingent Consideration, Liability, Current $4.04M.
- 2018-03-31: Business Combination, Contingent Consideration, Liability, Current $3.50M.
- 2017-12-31: Business Combination, Contingent Consideration, Liability, Current $3.29M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2023-12-31 | $3.30M 8-K · filed 2025-11-13 |
| 2023-09-30 | $4.04M 10-Q · filed 2023-11-06 |
| 2018-03-31 | $3.50M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $3.29M 10-K · filed 2019-02-28 |
| 2017-09-30 | $2.76M 10-Q · filed 2017-11-06 |
| 2017-03-31 | $5.94M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $5.55M 10-K · filed 2018-03-08 |
| 2016-09-30 | $4.99M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $6.57M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.44M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.25M 10-K · filed 2017-03-14 |
| 2014-12-31 | $5.71M 10-K · filed 2016-02-29 |
| 2014-09-30 | $3.43M 10-Q · filed 2014-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |